Home › Multiple Sclerosis › Wisconsin
Multiple Sclerosis clinical trials in Wisconsin
7 studies for Multiple Sclerosis are looking for participants at sites in Wisconsin.
Cities in Wisconsin
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Greenfield
- TG Therapeutics Investigational Trial Site, Milwaukee
- TG Therapeutics Investigational Trial Site, Neenah
- and 1 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06433752RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Wisconsin at Madison, Madison
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Medical College of Wisconsin, Milwaukee
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Sep 10, 2026 · NCT06408259A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Milwaukee
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06680037An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
- Research Site, Milwaukee
RecruitingPhase 1
Ages 18 to 60 · All sexes · Updated Aug 25, 2026 · NCT07224373Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- Brain Inflammation Collaborative, Delafield
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Jan 22, 2026 · NCT04806620High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis
- Marquette University, Milwaukee
Recruiting
Ages 18 to 75 · All sexes · Updated Jun 5, 2024 · NCT05735691From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.